Welcome to the Research Department at Weill Cornell Medicine - Qatar (WCM-Q). This portal provides you with

the latest developments regarding our rapidly growing research program. Our goal is to establish a state of the

art biomedical research program focused on tackling the most pressing health needs in Qatar and the region. Our vision is to undertake biomedical research at the basic, translational and community levels, with the expectation that such a combinatorial approach will have a dramatic impact in addressing complex multifactorial diseases such as diabetes.

Excellence and professionalism are our most prominent themes, and we strive to adhere to them in all aspects of our operations from the science we are producing, to our Core facilities, administrative services, and training programs. The WCM-Q research program is already contributing to building both biomedical research and human capacity in Qatar, and will continue to do so in the future. We employ a multipronged approach focused on recruiting exceptional scientists, delivering robust training programs, ensuring advanced infrastructure within the core laboratories, and a collaborative approach to produce cutting edge knowledge.

These are exciting times for our research program as it matures and contributes to the establishment of a knowledge based society in Qatar. I hope that browsing this site will convey the excitement and commitment of the entire WCM-Q research team as we endeavor to build a unique biomedical research center.

Khaled Machaca, PhD
Associate Dean for Research
Weill Cornell Medicine - Qatar 

In line with the national vision of Qatar and Qatar Foundation, the goal of the research program at Weill Cornell Medicine - Qatar (WCM-Q) is to establish a Center of Excellence in Basic, Translational and Clinical biomedical research with a world-class infrastructure, and outstanding scientists to target the most pressing health needs in Qatar and the region.

Establishing a robust research infrastructure and knowhow at the basic, translational and clinical levels generates a better understanding of diseases important in the Qatari and regional populations, including diabetes, obesity, metabolic syndrome; associated cardiovascular complications; and neurogenetic abnormalities. In collaboration with our partners Hamad Medical Corporation, Sidra Medical and Research Center, and the Weill Cornell Medicine in New York, we hope to improve our understanding of disease factors specific to the local population, to impact the efficiency and adaptability of health care delivery, and to usher in the era of personalized medicine in Qatar.